Pharmacogenomics

Facilitating a drug discovery ecosystem: Genestack joins the Milner Therapeutics Institute

October 30, 2017

“As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable dataset,” says Imad Yassin, Vice President of bio data management company Genestack. He is explaining why […]

Laboratory Informatics Leaders to Gather in Philadelphia

October 24, 2017

Philadelphia, PA  (October 20)  IQPC’s  14th Laboratory Informatics Summit, the nation’s foremost event addressing innovative solutions to leverage the modern lab will take place in Philadelphia, PA, this December 4-6, 2017. This summit will focus on key themes at the forefront of news today, such as leveraging the latest in machine learning to prepare for […]

A Summit on the Latest Research and Developments in the Emerging Treatment for Cancer – Immunotherapy.

July 20, 2017

A Summit on the Latest Research and Developments in the Emerging Treatment for Cancer – Immunotherapy. Vonlanthen Group of Companies will be hosting the 2nd Annual Cancer Immunotherapy Summit on September 21st – 22nd, 2017 in Vienna, Austria. Because of the success of the 1st Annual Cancer Immunotherapy Summit and the continued viability of immunotherapy […]

WIRB-Copernicus Group (WCG) Celebrates IBC Review Milestone

June 13, 2017

WIRB-Copernicus IRB Group® announced today that its Institutional Biosafety Committee Services (IBC Services) group has achieved a major milestone in administering 4,000 convened IBC meetings globally. Since 2001, WCG’s IBC Services has been the unrivaled leader in IBC administration. During the past 16 years, WCG IBC Services has administered IBCs for more than 580 institutions, reviewed […]

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

June 1, 2017

DURHAM, N.C., May 30, 2017 (GLOBE NEWSWIRE) — GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the appointments of Walter M. Capone as Chief Business Officer and Ellen Lubman to the company’s Board of Directors.  In his role as CBO, Mr. Capone […]

Burns & Levinson Expands Intellectual Property Practice with Addition of Three Life Sciences Partners

May 10, 2017

Boston, MA, May 10, 2017 – Burns & Levinson announced today that three highly accomplished life sciences attorneys – Daniel W. Clarke, Ph.D., Christopher R. Cowles, Ph.D., and Richard B. Emmons, Ph.D. – have joined the firm as partners in its Life Sciences and Intellectual Property (IP) Groups. Together, the team brings over three decades […]

FEEDBACK